June 13, 2017 / 12:45 PM / a month ago

BRIEF-AbbVie and Principia to collaborate on oral immunoproteasome inhibitors

1 Min Read

June 13 (Reuters) - AbbVie Inc-

* AbbVie and Principia announce collaboration on oral immunoproteasome inhibitors

* Financial terms were not disclosed

* AbbVie - upon successful completion, co will be responsible for ongoing clinical development and commercialization of viable compounds resulting from partnership

* AbbVie and Principia will collaborate on research and pre-clinical studies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below